Related references
Note: Only part of the references are listed.The Role of SIRT1 on DNA Damage Response and Epigenetic Alterations in Cancer
Debora Kristina Alves-Fernandes et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Cytoplasmic SIRT1 inhibits cell migration and invasion by impeding epithelial-mesenchymal transition in ovarian carcinoma
Tong Yang et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2019)
Rational Design and Synthesis of Reversible Covalent PPARγ Antagonistic Ligands Inhibiting Ser273 Phosphorylation
Hyunsoo Kim et al.
ASIAN JOURNAL OF ORGANIC CHEMISTRY (2019)
Sirtuin signaling in cellular senescence and aging
Shin-Hae Lee et al.
BMB REPORTS (2019)
Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells' vulnerability to DNA-damaging agents
Antonia Cagnetta et al.
HAEMATOLOGICA (2018)
The role of SIRT6 in tumors
Vanessa Desantis et al.
HAEMATOLOGICA (2018)
Chemically Induced Degradation of Sirtuin 2 (Sirt2) by a Proteolysis Targeting Chimera (PROTAC) Based on Sirtuin Rearranging Ligands (SirReals)
Matthias Schiedel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
The Current State of NAD(+)-Dependent Histone Deacetylases (Sirtuins) as Novel Therapeutic Targets
Matthias Schiedel et al.
MEDICINAL RESEARCH REVIEWS (2018)
Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells' vulnerability to DNA-damaging agents
Antonia Cagnetta et al.
HAEMATOLOGICA (2018)
The role of SIRT6 in tumors
Vanessa Desantis et al.
HAEMATOLOGICA (2018)
Opening the Selectivity Pocket in the Human Lysine Deacetylase Sirtuin2-New Opportunities, New Questions
Dina Robaa et al.
CHEMICAL RECORD (2018)
Recent advances in inhibitors of sirtuin1/2: an update and perspective
Ziyan Zhou et al.
FUTURE MEDICINAL CHEMISTRY (2018)
Narrower insight to SIRT1 role in cancer: A potential therapeutic target to control epithelial-mesenchymal transition in cancer cells
Jalal Choupani et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Sirtuin activators and inhibitors: Promises, achievements, and challenges
Han Dai et al.
PHARMACOLOGY & THERAPEUTICS (2018)
New chemical tools for probing activity and inhibition of the NAD(+)-dependent lysine deacylase sirtuin 2
Soeren Swyter et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2018)
Inhibition of sirtuins 1 and 2 impairs cell survival and migration and modulates the expression of P-glycoprotein and MRP3 in hepatocellular carcinoma cell lines
Maria Paula Ceballos et al.
TOXICOLOGY LETTERS (2018)
SIRT1 promotes formation of breast cancer through modulating Akt activity
Xiaoxia Jin et al.
JOURNAL OF CANCER (2018)
Novel small molecule SIRT2 inhibitors induce cell death in leukemic cell lines
Tomohiro Kozako et al.
BMC CANCER (2018)
Direct Comparison of SIRT2 Inhibitors: Potency, Specificity, Activity-Dependent Inhibition, and On-Target Anticancer Activities
Nicole A. Spiegelman et al.
CHEMMEDCHEM (2018)
Sirtuin 1-mediated deacetylation of XPA DNA repair protein enhances its interaction with ATR protein and promotes cAMP-induced DNA repair of UV damage (Publication with Expression of Concern. See vol. 295, pg. 14249, 2020) (Withdrawn Publication. See vol. 296, 2021)
Stuart G. Jarrett et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Identification of a cellularly active SIRT6 allosteric activator
Zhimin Huang et al.
NATURE CHEMICAL BIOLOGY (2018)
Breaking down the Contradictory Roles of Histone Deacetylase SIRT1 in Human Breast Cancer
Khaldoun Rifai et al.
CANCERS (2018)
KU70 Inhibition Impairs Both Non-Homologous End Joining and Homologous Recombination DNA Damage Repair Through SHP-1 Induced Dephosphorylation of SIRT1 in Adult T-Cell Leukemia-Lymphoma Cells
Wenlei Yu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Development of 1,2,4-Oxadiazoles as Potent and Selective Inhibitors of the Human Deacetylase Sirtuin 2: Structure-Activity Relationship, X-ray Crystal Structure, and Anticancer Activity
Sebastien Moniot et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
The prognostic role of Sirt1 expression in solid malignancies: a meta-analysis
Changwen Wang et al.
ONCOTARGET (2017)
SIRT1 Enhances the Survival of Human Embryonic Stem Cells by Promoting DNA Repair
Jiho Jang et al.
STEM CELL REPORTS (2017)
Effect of Sirtuin 1 inhibition on matrix metalloproteinase 2 and Forkhead box O3a expression in breast cancer cells
Hanan Abdelmawgoud et al.
GENES & DISEASES (2017)
Synthesis of novel spiro[pyrazolo[4,3-d]pyrimidinones and spiro[benzo[4,5]thieno[2,3-d]pyrimidine-2,3′-indoline]-2′,4(3H)-diones and their evaluation for anticancer activity
Ismail et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Identification of a Selective SIRT2 Inhibitor and Its Anti-breast Cancer Activity
Asad Ali Shah et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2016)
Functional characterization of NAD dependent de-acetylases SIRT1 and SIRT2 in B-Cell Chronic Lymphocytic Leukemia (CLL)
Savita Bhalla et al.
CANCER BIOLOGY & THERAPY (2016)
A SIRT2-Selective Inhibitor Promotes c-Myc Oncoprotein Degradation and Exhibits Broad Anticancer Activity
Hui Jing et al.
CANCER CELL (2016)
SIRT6 Overexpression Potentiates Apoptosis Evasion in Hepatocellular Carcinoma via BCL2-Associated X Protein-Dependent Apoptotic Pathway
Long-Kuan Ran et al.
CLINICAL CANCER RESEARCH (2016)
Aminothiazoles as Potent and Selective Sirt2 Inhibitors: A Structure-Activity Relationship Study
Matthias Schiedel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Sirtuin functions and modulation: from chemistry to the clinic
Vincenzo Carafa et al.
CLINICAL EPIGENETICS (2016)
The Role of SIRT1 in Cancer The Saga Continues
Melissa J. Wilking et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
Loss of Sirt1 Promotes Prostatic Intraepithelial Neoplasia, Reduces Mitophagy, and Delays Park2 Translocation to Mitochondria
Gabriele Di Sante et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
An exploratory double-blind, randomized clinical trial with selisistat, a SirT1 inhibitor, in patients with Huntington's disease
Sigurd D. Suessmuth et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Sirtuin 1 promotes the growth and cisplatin resistance of endometrial carcinoma cells: a novel therapeutic target
Ryoichi Asaka et al.
LABORATORY INVESTIGATION (2015)
Selectivity hot-spots of sirtuin catalytic cores
Marco Daniele Parenti et al.
MOLECULAR BIOSYSTEMS (2015)
Expression/localization patterns of sirtuins (SIRT1, SIRT2, and SIRT7) during progression of cervical cancer and effects of sirtuin inhibitors on growth of cervical cancer cells
Sapna Singh et al.
TUMOR BIOLOGY (2015)
Selective Sirt2 inhibition by ligand-induced rearrangement of the active site
Tobias Rumpf et al.
NATURE COMMUNICATIONS (2015)
Global Transcriptome Analysis of Formalin-Fixed Prostate Cancer Specimens Identifies Biomarkers of Disease Recurrence
Qi Long et al.
CANCER RESEARCH (2014)
Sirtuin deacetylases: A new target for melanoma management
Melissa J. Wilking et al.
CELL CYCLE (2014)
Non-specific SIRT inhibition as a mechanism for the cytotoxicity of ginkgolic acids and urushiols
Lucie Ryckewaert et al.
TOXICOLOGY LETTERS (2014)
Histone deacetylase SIRT1 modulates and deacetylates DNA base excision repair enzyme thymine DNA glycosylase
Amrita Madabushi et al.
BIOCHEMICAL JOURNAL (2013)
Recent developments in the use of differential scanning fluorometry in protein and small molecule discovery and characterization
Anton Simeonov
EXPERT OPINION ON DRUG DISCOVERY (2013)
The tumor suppressor SirT2 regulates cell cycle progression and genome stability by modulating the mitotic deposition of H4K20 methylation
Lourdes Serrano et al.
GENES & DEVELOPMENT (2013)
The 2.5 Å Crystal Structure of the SIRT1 Catalytic Domain Bound to Nicotinamide Adenine Dinucleotide (NAD+) and an Indole (EX527 Analogue) Reveals a Novel Mechanism of Histone Deacetylase Inhibition
Xun Zhao et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
On Terminal Alkynes That Can React with Active-Site Cysteine Nucleophiles in Proteases
Reggy Ekkebus et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)
The small molecule inhibitor PR-619 of deubiquitinating enzymes affects the microtubule network and causes protein aggregate formation in neural cells: Implications for neurodegenerative diseases
Veronika Seiberlich et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2012)
Thermodynamic studies for drug design and screening
Nichola C. Garbett et al.
EXPERT OPINION ON DRUG DISCOVERY (2012)
Sirtuins as regulators of metabolism and healthspan
Riekelt H. Houtkooper et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Inhibitors of the NAD+-Dependent Protein Desuccinylase and Demalonylase Sirt5
Benjamin Maurer et al.
ACS MEDICINAL CHEMISTRY LETTERS (2012)
Activity-Based Chemical Proteomics Accelerates Inhibitor Development for Deubiquitylating Enzymes
Mikael Altun et al.
CHEMISTRY & BIOLOGY (2011)
SIRT Inhibitors Induce Cell Death and p53 Acetylation through Targeting Both SIRT1 and SIRT2
Barrie Peck et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Dietary Sulforaphane, a Histone Deacetylase Inhibitor for Cancer Prevention
Emily Ho et al.
JOURNAL OF NUTRITION (2009)
A quantitative model of thermal stabilization and destabilization of proteins by ligands
Piotras Cimmperman et al.
BIOPHYSICAL JOURNAL (2008)
Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice
Rui-Hong Wang et al.
CANCER CELL (2008)
SIRT1 Redistribution on Chromatin Promotes Genomic Stability but Alters Gene Expression during Aging
Philipp Oberdoerffer et al.
CELL (2008)
The Sirtuin family: therapeutic targets to treat diseases of aging
Jill C. Milne et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2008)
Structure-activity studies on suramin analogues as inhibitors of NAD+-dependent histone deacetylases (Sirtuins)
Johannes Trapp et al.
CHEMMEDCHEM (2007)
SIRT1 promotes DNA repair activity and deacetylation of Ku70
Jaemin Jeong et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2007)
The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability
Frank H. Niesen et al.
NATURE PROTOCOLS (2007)
Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage
Chuangui Wang et al.
NATURE CELL BIOLOGY (2006)
Discovery of indoles as potent and selective inhibitors of the deacetylase SIRT1
AD Napper et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
In vitro assays for the determination of histone deacetylase activity
B Heltweg et al.
METHODS (2005)
Mechanism of human SIRT1 activation by resveratrol
MT Borra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
SIRT1 regulates HIV transcription via Tat deacetylation
S Pagans et al.
PLOS BIOLOGY (2005)
Development and testing of a general amber force field
JM Wang et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Mechanism and function of deubiquitinating enzymes
AY Amerik et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2004)
Modulation of NF-κB-dependent transcription and cell survival by the SIRT1 deacetylase
F Yeung et al.
EMBO JOURNAL (2004)
Applications of calorimetric methods to drug discovery and the study of protein interactions
PC Weber et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2003)
Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation
A Jakalian et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2002)
hSIR2SIRT1 functions as an NAD-dependent p53 deacetylase
H Vaziri et al.
CELL (2001)
Share Paper
